From stem cells to germ cell tumors and back

Area of Science:

• Developmental biology
• Cancer stem cell research
• Reproductive medicine

Background:

• Germ cell tumors originate from ovarian, testicular, and extragonadal germ cells.
• Tumor stem cells can differentiate into seminomas, dysgerminomas, teratomas, or teratocarcinomas.
• Teratocarcinomas share similarities with early embryonic cells and can be experimentally induced in mice.

Purpose of the Study:

• To investigate the behavior and potential of malignant embryonal carcinoma (EC) cells and non-neoplastic embryonic stem (ES) cells.
• To explore the use of these cells in generating experimental models and potential therapeutic applications.
• To compare the characteristics of mouse and human EC and ES cells.

Main Methods:

• Isolation and culture of malignant EC cells from teratocarcinomas.
• In vitro culture of mouse and human blastocysts to derive ES cells.
• Injection of EC and ES cells into mouse blastocysts and adult mice.
• Isotransplantation of EC cells into syngeneic mice.

Main Results:

• Malignant EC cells lose malignancy and participate in normal blastocyst development when injected into blastocysts, enabling transgenic mouse generation.
• Non-neoplastic mouse ES cells, derived from blastocysts, form teratomas when injected into adult mice, unlike EC cells which can form teratocarcinomas.
• Human ES cells, derived from human blastocysts, resemble mouse ES cells and form teratomas in nude mice, differing from human EC cells.

Conclusions:

• EC cells can revert to a benign state and contribute to normal development within the embryonic environment.
• Both mouse and human ES cells hold potential for generating disease models and future cell-based therapies.
• Understanding the differences between EC and ES cells is crucial for their application in research and medicine.